These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3783744

  • 41. The relationships of high energy phosphates, tissue pH, and regional blood flow to diastolic distensibility in the ischemic dog myocardium.
    Momomura S, Ingwall JS, Parker JA, Sahagian P, Ferguson JJ, Grossman W.
    Circ Res; 1985 Dec; 57(6):822-35. PubMed ID: 4064257
    [Abstract] [Full Text] [Related]

  • 42. Dependency of location of salvageable myocardium on type of intervention.
    Darsee JR, Kloner RA.
    Am J Cardiol; 1981 Oct; 48(4):702-10. PubMed ID: 7282552
    [Abstract] [Full Text] [Related]

  • 43. Protective effect of early and late treatment with nifedipine during myocardial infarction in the conscious dog.
    Melin JA, Becker LC, Hutchins GM.
    Circulation; 1984 Jan; 69(1):131-41. PubMed ID: 6689637
    [Abstract] [Full Text] [Related]

  • 44. Nifedipine limits infarct size via NO-dependent mechanisms in dogs.
    Asanuma H, Kitakaze M, Funaya H, Takashima S, Minamino T, Node K, Sakata Y, Asakura M, Sanada S, Shinozaki Y, Mori H, Kuzuya T, Tada M, Hori M.
    Basic Res Cardiol; 2001 Sep; 96(5):497-505. PubMed ID: 11605997
    [Abstract] [Full Text] [Related]

  • 45. Effects of nifedipine on myocardial perfusion and ischemic injury in dogs.
    Henry PD, Shuchleib R, Borda LJ, Roberts R, Williamson JR, Sobel BE.
    Circ Res; 1978 Sep; 43(3):372-80. PubMed ID: 679420
    [Abstract] [Full Text] [Related]

  • 46. Determinants of infarct size during permanent occlusion of a coronary artery in the closed chest dog.
    Miura T, Yellon DM, Hearse DJ, Downey JM.
    J Am Coll Cardiol; 1987 Mar; 9(3):647-54. PubMed ID: 3819209
    [Abstract] [Full Text] [Related]

  • 47. Inability of metoprolol to achieve a sustained limitation of infarct size 24 h after coronary artery embolization in the closed chest dog.
    Kudoh Y, Maxwell MP, Hearse DJ, Downey JM, Yellon DM.
    J Cardiovasc Pharmacol; 1984 Mar; 6(6):1201-9. PubMed ID: 6084780
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Effects of nisoldipine, a new calcium antagonist, on myocardial infarct size and cardiac dynamics following acute myocardial infarction.
    Tumas J, Deth R, Kloner RA.
    J Cardiovasc Pharmacol; 1985 Mar; 7(2):361-7. PubMed ID: 2581092
    [Abstract] [Full Text] [Related]

  • 51. Basic fibroblast growth factor increases regional myocardial blood flow and salvages myocardium in the infarct border zone in a rabbit model of acute myocardial infarction.
    Hasegawa T, Kimura A, Miyataka M, Inagaki M, Ishikawa K.
    Angiology; 1999 Jun; 50(6):487-95. PubMed ID: 10378825
    [Abstract] [Full Text] [Related]

  • 52. Cloricromene reduces infarct size and alters postischaemic blood flow defects in dog myocardium.
    Groban L, Zvara DA, Deal DD, Vernon JC, Flye CW, Ma XL, Vinten-Johansen J.
    Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):417-23. PubMed ID: 9673816
    [Abstract] [Full Text] [Related]

  • 53. Effects of nicorandil and nifedipine on protection of ischemic myocardium.
    Lamping KA, Christensen CW, Pelc LR, Warltier DC, Gross GJ.
    J Cardiovasc Pharmacol; 1984 Jun; 6(3):536-42. PubMed ID: 6202983
    [Abstract] [Full Text] [Related]

  • 54. Acute coronary occlusion: prolonged increase in collateral flow following brief administration of nitroglycerin and methoxamine.
    Capurro NL, Kent KM, Smith HJ, Aamodt R, Epstein SE.
    Am J Cardiol; 1977 May 04; 39(5):679-83. PubMed ID: 404862
    [Abstract] [Full Text] [Related]

  • 55. Myocardial energy metabolism in ischemic preconditioning and cardioplegia: a metabolic control analysis.
    Vogt AM, Elsässer A, Pott-Beckert A, Ackermann C, Vetter SY, Yildiz M, Schoels W, Fell DA, Katus HA, Kübler W.
    Mol Cell Biochem; 2005 Oct 04; 278(1-2):223-32. PubMed ID: 16180108
    [Abstract] [Full Text] [Related]

  • 56. Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated with anatomic evidence of necrosis.
    DeBoer LW, Ingwall JS, Kloner RA, Braunwald E.
    Proc Natl Acad Sci U S A; 1980 Sep 04; 77(9):5471-5. PubMed ID: 6933566
    [Abstract] [Full Text] [Related]

  • 57. A low concentration of nisoldipine reduces ischemic heart injury: enhanced reflow and recovery of contractile function without energy preservation during ischemia.
    Watts JA, Whipple JP, Hatley AA.
    J Mol Cell Cardiol; 1987 Aug 04; 19(8):809-16. PubMed ID: 3694681
    [Abstract] [Full Text] [Related]

  • 58. Spatial distribution of [14C]-lidocaine and blood flow in transmural and lateral border zones of ischemic canine myocardium.
    Patterson RE, Weintraub WS, Halgash DA, Miao J, Rogers JR, Kupersmith J.
    Am J Cardiol; 1982 Jul 04; 50(1):63-73. PubMed ID: 7091007
    [Abstract] [Full Text] [Related]

  • 59. Comparative effects of nitroglycerin and nifedipine on myocardial blood flow and contraction during flow-limiting coronary stenosis in the dog.
    Weintraub WS, Akizuki S, Agarwal JB, Bodenheimer MM, Banka VS, Helfant RH.
    Am J Cardiol; 1982 Aug 04; 50(2):281-8. PubMed ID: 6808819
    [Abstract] [Full Text] [Related]

  • 60. Long-term preservation of ischemic myocardium in the dog by hyaluronidase.
    Kloner RA, Braunwald E, Maroko PR.
    Circulation; 1978 Aug 04; 58(2):220-6. PubMed ID: 668070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.